---
schema_version: "secwatch.filing_event.v1"
accession: "0001370053-25-000083"
form_type: "8-K"
ticker: "ANAB"
cik: "0001370053"
company_name: "ANAPTYSBIO, INC"
filed_at: "2025-10-14T23:59:59+00:00"
generated_at: "2026-05-17T03:51:53.622643+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "low"
source: SEC EDGAR
---

# AnaptysBio holds ANB033 (CD122 antagonist) investor event; updates corporate presentation

## Summary
- Conference call and slide presentation on ANB033 (CD122 antagonist) held on October 14, 2025.
- Updated corporate investor presentation filed as Exhibit 99.2; no specific clinical or financial data disclosed in the filing text.
- Event intended to provide pipeline update; details of ANB033 discussion not expanded in the filing.

## SEC filing metadata
- accession: 0001370053-25-000083
- form_type: 8-K
- ticker: ANAB
- cik: 0001370053
- company_name: ANAPTYSBIO, INC
- filed_at: 2025-10-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1370053/000137005325000083/0001370053-25-000083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1370053/000137005325000083/anab-20251014.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001370053-25-000083
- JSON: https://secwatch.observer/filing/0001370053-25-000083.json
- Plain text: https://secwatch.observer/filing/0001370053-25-000083.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.